Suppression of SOCS3 enhances TRAIL-induced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells.

Yabe, Michihiro; Ishibashi, Kei; Onagi, Akifumi; Tanji, Ryo; Honda-Takinami, Ruriko; Koguchi, Tomoyuki; Matsuoka, Kanako; Hoshi, Seiji; Hata, Junya; Kataoka, Masao; Ogawa, Soichiro; Hiraki, Hiroyuki; Haga, Nobuhiro; Kojima, Yoshiyuki.

Afiliação

Yabe M; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Ishibashi K; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Onagi A; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Tanji R; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Honda-Takinami R; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Koguchi T; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Matsuoka K; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Hoshi S; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Hata J; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Kataoka M; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Ogawa S; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Hiraki H; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Haga N; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Kojima Y; Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan.